Skip to main content

New innovative treatments for hemophilia B, RSV, COPD

Cutting-edge research in gene therapy, mRNA editing and blood enzymes pays off with powerful new advances for these drug classes.

Title

Novel treatments, increased choice and competition

This edition of the Drug Pipeline Insights Report showcases:

  • Second gene therapy for hemophilia B
  • Nontraditional RSV vaccine
  • Maintenance treatment for COPD

Download now

View summary

Start strategizing for these new drugs with Optum Rx

Learn more

Related content

Winter: First big drugs for 2024

New treatments for NASH, schizophrenia and more are on the way.
Read more

A young patient’s hemophilia story

See how OptumRx helped change a patient’s life.
Read more

Optum Rx Drug Pipeline Insights Reports

Read the most recent quarterly reports on new drugs coming down the pipeline.
Read more